Latest Information
February 8th, 2017
Patients with kidney tumors with pathology indicating a fumarate hydratase (FH) mutation should be referred for genetic testing, according to an article published in Cancer.1 Results from these tests can determine whether a patient and/or his or her family members should go on targeted surveillance for recurrent tumors.
December 19th, 2016
Statin use in patients with kidney cancer improved cancer-specific survival and overall survival, according to the results of a meta-analysis published recently in Cancer Treatment Reviews. There was, however, no effect on recurrence-free or progression-free survival
November 16, 2016
Among patients with intermediate- or poor-risk metastatic renal cell carcinoma (mRCC), first-line therapy with cabozantinib was superior to standard-of-care sunitinib with respect to objective response rate and progression-free survival, according to a study published in the Journal of Clinical Oncology
Print this page Tell A Friend Add to Favorites

Dr. Kevin Zbuk

B.Sc. (Alberta), MD (Alberta), FRCPC


Assistant Professor, McMaster University
Department of Oncology - Division of Medical Oncology




Office:

Juravinski Cancer Centre
3rd Floor
699 Concession Street
Hamilton Ontario, L8V 5C2

Contact Information:
P: 905-387-9711 Ext. 64602
F: 905-575-6326
E:kevin.zbuk@jcc.hhsc.ca

Support Staff:
Karen Chadwick (Administrative Assistant)
P: 905-387-9711 Ext. 64602
F: 905-575-6326
E: Karen.Chadwick@jcc.hhsc.ca

Areas of Interest

Dr. Zbuk's areas of interest include cancer genetics and the molecular classification of gastrointestinal polyposis syndromes. Dr. Zbuk's oncology practice focuses on gastrointestinal malignancies.

Selected Publications

Zbuk K and Eng C “Cancer Phenomics: RET and PTEN as illustrative models”. Nature Reviews Cancer. 2007 Jan;7(1):35-45.

Ni Y*, Zbuk K*, Sadler T, et. al. « Germline mutations and variants in the succinate dehydrogenase genes in Cowden andCowden-like syndromes” American Journal of Human Genetics 2008 (in press)

Plon, S.E., Pirics, M.L., Agrawal, S., Zbuk, K., Nuchtern, J., Hicks, J., Hegde, M., Lip-Hon Chin, E., Eng, C., and H. Russell (2008). Multiple Tumors in a Child with Germline Mutations in TP53 and PTEN. New England J of Medicine, in press.

* joint first authors